PL3263589T3 - Sekwencje i kompozycje peptydów - Google Patents

Sekwencje i kompozycje peptydów

Info

Publication number: PL3263589T3
Authority: PL; Poland
Prior art keywords: compositions; peptide sequences; peptide; sequences
Prior art date: 2006-02-07

Application number

PL17180723T

Other languages

English (en)

Inventor

Wilson Romero Caparrós-Wanderley

Gregory Alan Stoloff

Original Assignee

Peptcell Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-02-07

Filing date

2007-02-05

Publication date

2020-07-13

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38109631&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3263589(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-02-07 Priority claimed from GB0602416A external-priority patent/GB0602416D0/en

2007-02-05 Application filed by Peptcell Limited filed Critical Peptcell Limited

2020-07-13 Publication of PL3263589T3 publication Critical patent/PL3263589T3/pl

Links

239000000203 mixture Substances 0.000 title 1
108090000765 processed proteins & peptides Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/11—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16171—Demonstrated in vivo effect
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16271—Demonstrated in vivo effect

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Transplantation (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL17180723T 2006-02-07 2007-02-05 Sekwencje i kompozycje peptydów PL3263589T3 (pl)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
GB0602416A GB0602416D0 (en)	2006-02-07	2006-02-07	Peptide sequences and compositions
GBGB0613977.8A GB0613977D0 (en)	2006-02-07	2006-07-13	Peptide sequences and compositions
EP07712678A EP1991563B1 (en)	2006-02-07	2007-02-05	Peptide sequences and compositions
EP11157383.8A EP2383285B1 (en)	2006-02-07	2007-02-05	Peptide Sequences and Compositions
PCT/GB2007/000383 WO2007091030A2 (en)	2006-02-07	2007-02-05	Peptide sequences and compositions
EP17180723.3A EP3263589B1 (en)	2006-02-07	2007-02-05	Peptide sequences and compositions

Publications (1)

Publication Number	Publication Date
PL3263589T3 true PL3263589T3 (pl)	2020-07-13

Family

ID=38109631

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
PL07712678T PL1991563T3 (pl)	2006-02-07	2007-02-05	Sekwencje peptydowe i kompozycje
PL11157383T PL2383285T3 (pl)	2006-02-07	2007-02-05	Sekwencje peptydowe i kompozycje
PL17180723T PL3263589T3 (pl)	2006-02-07	2007-02-05	Sekwencje i kompozycje peptydów
PL11157382T PL2383284T3 (pl)	2006-02-07	2007-02-05	Sekwencje i kompozycje peptydowe

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
PL07712678T PL1991563T3 (pl)	2006-02-07	2007-02-05	Sekwencje peptydowe i kompozycje
PL11157383T PL2383285T3 (pl)	2006-02-07	2007-02-05	Sekwencje peptydowe i kompozycje

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL11157382T PL2383284T3 (pl)	2006-02-07	2007-02-05	Sekwencje i kompozycje peptydowe

Country Status (23)

Country	Link
US (10)	US8475802B2 (pl)
EP (6)	EP1991563B1 (pl)
JP (1)	JP5603551B2 (pl)
KR (1)	KR20080100441A (pl)
CN (3)	CN102382179B (pl)
AP (1)	AP2646A (pl)
AT (1)	ATE534660T1 (pl)
AU (1)	AU2007213562A1 (pl)
BR (1)	BRPI0707543B8 (pl)
CA (1)	CA2641602A1 (pl)
DK (4)	DK2383284T3 (pl)
EA (1)	EA017387B1 (pl)
ES (4)	ES2611034T3 (pl)
GB (1)	GB0613977D0 (pl)
HK (1)	HK1249115A1 (pl)
IL (2)	IL193232A (pl)
MX (1)	MX2008010113A (pl)
NO (1)	NO20083416L (pl)
NZ (1)	NZ570553A (pl)
PL (4)	PL1991563T3 (pl)
PT (1)	PT1991563E (pl)
SG (1)	SG169392A1 (pl)
WO (1)	WO2007091030A2 (pl)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0408164D0 (en)	2004-04-13	2004-05-19	Immune Targeting Systems Ltd	Antigen delivery vectors and constructs
GB0716992D0 (en) *	2007-08-31	2007-10-10	Immune Targeting Systems Its L	Influenza antigen delivery vectors and constructs
GB0613977D0 (en)	2006-02-07	2006-08-23	Peptcell Ltd	Peptide sequences and compositions
US8080645B2 (en)	2007-10-01	2011-12-20	Longhorn Vaccines & Diagnostics Llc	Biological specimen collection/transport compositions and methods
US8097419B2 (en)	2006-09-12	2012-01-17	Longhorn Vaccines & Diagnostics Llc	Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
US9481912B2 (en)	2006-09-12	2016-11-01	Longhorn Vaccines And Diagnostics, Llc	Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
WO2009016639A2 (en)	2007-08-02	2009-02-05	Biondvax Pharmaceuticals Ltd.	Multimeric multiepitope influenza vaccines
US9683256B2 (en)	2007-10-01	2017-06-20	Longhorn Vaccines And Diagnostics, Llc	Biological specimen collection and transport system
US11041215B2 (en)	2007-08-24	2021-06-22	Longhorn Vaccines And Diagnostics, Llc	PCR ready compositions and methods for detecting and identifying nucleic acid sequences
US10004799B2 (en)	2007-08-27	2018-06-26	Longhorn Vaccines And Diagnostics, Llc	Composite antigenic sequences and vaccines
CA2697373C (en)	2007-08-27	2019-05-21	Longhorn Vaccines & Diagnostics, Llc	Immunogenic compositions and methods
US11041216B2 (en)	2007-10-01	2021-06-22	Longhorn Vaccines And Diagnostics, Llc	Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
AU2008343745B2 (en)	2007-10-01	2012-05-10	Longhorn Vaccines & Diagnostics Llc	Biological specimen collection and transport system and methods of use
GB0719526D0 (en)	2007-10-05	2007-11-14	Isis Innovation	Compositions and methods
EP2072529A1 (en) *	2007-12-21	2009-06-24	basisnote AG	MHC rapid assay used for the customization of odours
FR2962739B1 (fr) *	2010-07-13	2014-01-31	Univ Claude Bernard Lyon	Souches virales modifiees et procede pour ameliorer la production de semences vaccinales de virus influenza
WO2012114323A1 (en)	2011-02-22	2012-08-30	Biondvax Pharmaceuticals Ltd.	Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
WO2013093514A2 (en) *	2011-12-23	2013-06-27	Retroscreen Virology Ltd	Vaccines - peptides
CA3207612A1 (en)	2012-01-26	2013-08-01	Longhorn Vaccines And Diagnostics, Llc	Composite antigenic sequences and vaccines
CN107106668A (zh) *	2014-12-10	2017-08-29	华西亚生医有限公司	用于免疫中的有效抗体生产的新颖蛋白质结构
EP3294448A4 (en)	2015-05-14	2018-12-12	Longhorn Vaccines and Diagnostics, LLC	Rapid methods for the extraction of nucleic acids from biological samples
CN106310214A (zh) *	2015-06-30	2017-01-11	中国科学院上海巴斯德研究所	流感病毒蛋白与宿主蛋白cpsf30的相互作用在抑制癌细胞增殖中的应用
JP2019064924A (ja) *	2016-02-24	2019-04-25	Ａｇｃ株式会社	インフルエンザワクチン
KR101888751B1 (ko) *	2016-09-22	2018-09-21	이화여자대학교 산학협력단	인플루엔자 b 백신
BR112019013402A2 (pt)	2016-12-28	2020-03-03	Invvax, Inc.	Vacinas de influenza
CA3086456A1 (en)	2017-12-21	2019-06-27	Kirin Holdings Kabushiki Kaisha	Cross-immunizing antigen vaccine and method for preparation thereof
EP3980060A4 (en)	2019-06-07	2023-04-12	Flugen, Inc.	FLU VIRUS BACKBONE
WO2022020469A1 (en) *	2020-07-21	2022-01-27	Flugen, Inc.	Influenza virus backbone

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4981782A (en)	1987-05-14	1991-01-01	Sri International	Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
US5741493A (en) *	1991-01-24	1998-04-21	Pasteur Merieux Serums Et Vaccins	Vaccine composition against influenza, with synergic effects, containing influenza virus core as an additive
IL101639A0 (en) *	1992-04-17	1992-12-30	Yeda Res & Dev	Recombinant influenza vaccines
IL106610A0 (en) *	1992-08-07	1993-12-08	Cytel Corp	Hla binding peptides and their uses
US20040087521A1 (en) *	1993-03-18	2004-05-06	Merck & Co., Inc.	Nucleic acid pharmaceuticals-influenza matrix
IL109664A0 (en)	1993-05-18	1994-08-26	Rijksuniversiteit	Peptides of human influenza virus for use in human t cell response inducing compositions
US6939546B2 (en)	1993-05-21	2005-09-06	The United States Of America As Represented By The Secretary Of The Army	Model for testing immunogenicity of peptides
FR2718452B1 (fr) *	1994-04-06	1996-06-28	Pf Medicament	Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
AU3727895A (en)	1994-09-30	1996-04-26	St. Jude Children's Research Hospital	Nucleic acid encoding mutant matrix proteins useful for attenuation or enhancement of influenza a virus
US7269219B1 (en) *	1997-02-14	2007-09-11	At&T Corp.	Non-linear quantizer for video coding
IL127331A0 (en)	1998-11-30	1999-09-22	Yeda Res & Dev	Peptide-based vaccine for influenza
JP2001151698A (ja) *	1999-09-10	2001-06-05	Nichiko Pharmaceutical Co Ltd	インフルエンザワクチン
WO2002026252A1 (en)	2000-08-10	2002-04-04	Tsinghua University	A vaccine for influenza virus and its preparation
ATE434035T1 (de) *	2000-09-25	2009-07-15	Polymun Scient Immunbio Forsch	Lebender influenza impfstoff und verfahren zu seiner herstellung
US6906169B2 (en) *	2001-05-25	2005-06-14	United Biomedical, Inc.	Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
US20050013826A1 (en) *	2002-12-20	2005-01-20	Shneider Alexander M.	Vaccine compositions and methods
CA2807534A1 (en) *	2003-02-25	2005-02-17	Medimmune Vaccines, Inc.	Methods of producing influenza vaccine compositions
EP1603590A4 (en)	2003-03-07	2008-08-27	Merck & Co Inc	INFLUENZA VIRUS VACCINE
US8592197B2 (en) *	2003-07-11	2013-11-26	Novavax, Inc.	Functional influenza virus-like particles (VLPs)
DE102004052026B4 (de) *	2003-11-07	2015-08-27	Totankako Co., Ltd.	Kollektor
FR2863758B1 (fr) *	2003-12-11	2006-07-14	Centre Nat Rech Scient	Cellule de commande electronique pour diode electroluminescente organique d'afficheur a matrice active, procedes de fonctionnement et afficheur
GB0408164D0 (en)	2004-04-13	2004-05-19	Immune Targeting Systems Ltd	Antigen delivery vectors and constructs
JP5331340B2 (ja)	2004-05-18	2013-10-30	バイカルインコーポレイテッド	インフルエンザウィルスワクチン組成物、及びその使用方法
MX358750B (es) *	2005-04-21	2018-08-31	Univ Florida	Materiales y metodos para el control de enfermedades respiratorias en caninos.
US20070116717A1 (en)	2005-08-01	2007-05-24	Shneider Alexander M	Influenza vaccine compositions and methods
CA2638815A1 (en)	2006-02-02	2007-08-16	Globeimmune, Inc.	Yeast-based vaccine for inducing an immune response
GB0613977D0 (en) *	2006-02-07	2006-08-23	Peptcell Ltd	Peptide sequences and compositions

2006
- 2006-07-13 GB GBGB0613977.8A patent/GB0613977D0/en not_active Ceased
2007
- 2007-02-05 AP AP2008004571A patent/AP2646A/xx active
- 2007-02-05 EA EA200870237A patent/EA017387B1/ru not_active IP Right Cessation
- 2007-02-05 CN CN201110311189.2A patent/CN102382179B/zh not_active Expired - Fee Related
- 2007-02-05 PL PL07712678T patent/PL1991563T3/pl unknown
- 2007-02-05 EP EP07712678A patent/EP1991563B1/en not_active Revoked
- 2007-02-05 AT AT07712678T patent/ATE534660T1/de active
- 2007-02-05 WO PCT/GB2007/000383 patent/WO2007091030A2/en not_active Ceased
- 2007-02-05 CN CN2007800079350A patent/CN101395176B/zh not_active Expired - Fee Related
- 2007-02-05 CA CA002641602A patent/CA2641602A1/en not_active Abandoned
- 2007-02-05 CN CN201210252429.0A patent/CN102807608B/zh not_active Expired - Fee Related
- 2007-02-05 AU AU2007213562A patent/AU2007213562A1/en not_active Abandoned
- 2007-02-05 MX MX2008010113A patent/MX2008010113A/es active IP Right Grant
- 2007-02-05 DK DK11157382.0T patent/DK2383284T3/en active
- 2007-02-05 EP EP11157383.8A patent/EP2383285B1/en active Active
- 2007-02-05 PL PL11157383T patent/PL2383285T3/pl unknown
- 2007-02-05 NZ NZ570553A patent/NZ570553A/xx not_active IP Right Cessation
- 2007-02-05 DK DK07712678.7T patent/DK1991563T3/da active
- 2007-02-05 BR BRPI0707543A patent/BRPI0707543B8/pt not_active IP Right Cessation
- 2007-02-05 DK DK17180723.3T patent/DK3263589T5/da active
- 2007-02-05 EP EP17210264.2A patent/EP3320918A3/en not_active Withdrawn
- 2007-02-05 PL PL17180723T patent/PL3263589T3/pl unknown
- 2007-02-05 ES ES11157382.0T patent/ES2611034T3/es active Active
- 2007-02-05 EP EP11157382.0A patent/EP2383284B1/en active Active
- 2007-02-05 DK DK11157383.8T patent/DK2383285T3/en active
- 2007-02-05 PT PT07712678T patent/PT1991563E/pt unknown
- 2007-02-05 EP EP19192958.7A patent/EP3620463A1/en not_active Ceased
- 2007-02-05 ES ES07712678T patent/ES2374841T3/es active Active
- 2007-02-05 JP JP2008553817A patent/JP5603551B2/ja active Active
- 2007-02-05 EP EP17180723.3A patent/EP3263589B1/en active Active
- 2007-02-05 SG SG201100861-2A patent/SG169392A1/en unknown
- 2007-02-05 US US12/278,728 patent/US8475802B2/en not_active Expired - Fee Related
- 2007-02-05 PL PL11157382T patent/PL2383284T3/pl unknown
- 2007-02-05 ES ES17180723T patent/ES2790730T3/es active Active
- 2007-02-05 ES ES11157383.8T patent/ES2635590T3/es active Active
- 2007-02-05 KR KR1020087021658A patent/KR20080100441A/ko not_active Ceased
2008
- 2008-08-04 NO NO20083416A patent/NO20083416L/no not_active Application Discontinuation
- 2008-08-04 IL IL193232A patent/IL193232A/en active IP Right Grant
2012
- 2012-05-07 US US13/465,940 patent/US8444995B2/en active Active
2013
- 2013-05-30 US US13/906,232 patent/US9446116B2/en active Active
2016
- 2016-08-08 US US15/231,347 patent/US9889191B2/en active Active
2017
- 2017-04-23 IL IL251867A patent/IL251867B/en active IP Right Grant
2018
- 2018-01-08 US US15/865,214 patent/US10279032B2/en active Active
- 2018-01-22 US US15/876,781 patent/US10335480B2/en active Active
- 2018-07-03 HK HK18108547.1A patent/HK1249115A1/en unknown
2019
- 2019-03-07 US US16/295,488 patent/US10765734B2/en active Active
- 2019-08-14 US US16/540,811 patent/US20190365883A1/en not_active Abandoned
2020
- 2020-09-04 US US17/013,000 patent/US11439702B2/en active Active
2022
- 2022-09-09 US US17/931,017 patent/US20230233660A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2635590T3 (es)	2017-10-04
US20200397889A1 (en)	2020-12-24
PL2383284T3 (pl)	2017-07-31
EP3620463A1 (en)	2020-03-11
US20230233660A1 (en)	2023-07-27
DK1991563T3 (da)	2012-01-23
DK2383284T3 (en)	2016-12-12
US20100047275A1 (en)	2010-02-25
IL193232A0 (en)	2009-02-11
WO2007091030A2 (en)	2007-08-16
US10765734B2 (en)	2020-09-08
IL193232A (en)	2017-05-29
US8444995B2 (en)	2013-05-21
PT1991563E (pt)	2011-12-29
DK2383285T3 (en)	2017-08-28
NO20083416L (no)	2008-11-07
KR20080100441A (ko)	2008-11-18
BRPI0707543A2 (pt)	2011-05-03
EP1991563B1 (en)	2011-11-23
US20120219575A1 (en)	2012-08-30
EP3263589A3 (en)	2018-02-14
DK3263589T3 (da)	2020-05-11
EP2383284A3 (en)	2012-05-30
CA2641602A1 (en)	2007-08-16
US10279032B2 (en)	2019-05-07
CN101395176B (zh)	2013-02-06
CN102807608B (zh)	2015-01-21
US20180185470A1 (en)	2018-07-05
EP3263589A2 (en)	2018-01-03
BRPI0707543B1 (pt)	2020-11-24
US20170028053A1 (en)	2017-02-02
EP2383285A3 (en)	2012-05-16
CN101395176A (zh)	2009-03-25
US20190201519A1 (en)	2019-07-04
EP2383285A2 (en)	2011-11-02
ES2374841T3 (es)	2012-02-22
CN102382179A (zh)	2012-03-21
US20180147277A1 (en)	2018-05-31
GB0613977D0 (en)	2006-08-23
CN102807608A (zh)	2012-12-05
BRPI0707543B8 (pt)	2021-05-25
ATE534660T1 (de)	2011-12-15
AU2007213562A1 (en)	2007-08-16
EA200870237A1 (ru)	2009-06-30
NZ570553A (en)	2012-08-31
US11439702B2 (en)	2022-09-13
SG169392A1 (en)	2011-03-30
DK3263589T5 (da)	2020-05-25
US20130243804A1 (en)	2013-09-19
EP1991563A2 (en)	2008-11-19
EP2383285B1 (en)	2017-07-12
JP5603551B2 (ja)	2014-10-08
HK1249115A1 (en)	2018-10-26
MX2008010113A (es)	2009-01-19
EP3320918A3 (en)	2018-08-01
EP3263589B1 (en)	2020-03-25
PL1991563T3 (pl)	2012-02-29
PL2383285T3 (pl)	2017-11-30
IL251867B (en)	2018-06-28
ES2790730T3 (es)	2020-10-29
US9446116B2 (en)	2016-09-20
AP2008004571A0 (en)	2008-08-31
ES2611034T3 (es)	2017-05-04
CN102382179B (zh)	2014-01-22
AU2007213562A2 (en)	2008-11-20
US20190365883A1 (en)	2019-12-05
WO2007091030A3 (en)	2007-11-08
US8475802B2 (en)	2013-07-02
AP2646A (en)	2013-04-17
JP2009526028A (ja)	2009-07-16
EP2383284B1 (en)	2016-08-24
IL251867A0 (en)	2017-06-29
US9889191B2 (en)	2018-02-13
EA017387B1 (ru)	2012-12-28
US10335480B2 (en)	2019-07-02
EP2383284A2 (en)	2011-11-02
EP3320918A2 (en)	2018-05-16

Publication	Publication Date	Title
IL251867A0 (en)	2017-06-29	Peptide sequences and compounds
GB0717864D0 (en)	2007-10-24	Peptide sequences and compositions
PT2178549T (pt)	2016-12-20	Péptido antimicrobiano e suas composições
IL187617A0 (en)	2008-03-20	Lkktet and/or lkktnt peptide compositions and methods
EP2017283A4 (en)	2015-12-30	Peptides
EP1976864A4 (en)	2010-09-01	NEW PEPTIDE AND ITS USE
IL195525A0 (en)	2011-08-01	Replikin peptides and uses thereof
GB0622399D0 (en)	2006-12-20	Novel compositions and uses thereof
PL2392587T3 (pl)	2016-08-31	Sekwencje i kompozycje peptydów
GB0617171D0 (en)	2006-10-11	Novel compositions and methods
GB0604187D0 (en)	2006-04-12	Peptide and uses thereof
IL192800A0 (en)	2009-02-11	Fgf2-binding peptides and uses thereof
EP2010141A4 (en)	2011-05-04	NUCLEOTIDE COMPOSITIONS HAVING HIGH DEPOSITS AND USES THEREOF
GB0618748D0 (en)	2006-11-01	Peptide
GB0622400D0 (en)	2006-12-20	Novel compositions and uses thereof
EP2091959A4 (en)	2010-05-05	IMPROVED PEPTIDE COMPOSITION
GB0602416D0 (en)	2006-03-15	Peptide sequences and compositions
GB0604920D0 (en)	2006-04-19	Peptide sequences and compositions
GB0614260D0 (en)	2006-08-30	Peptide sequences and compositions
GB0605774D0 (en)	2006-05-03	Peptide
HK1143743A (en)	2011-01-14	Peptide sequences and compositions
PL378824A1 (pl)	2007-08-06	Peptyd i jego zastosowanie
GB0612873D0 (en)	2006-08-09	Isolated peptides and uses thereof
GB0625230D0 (en)	2007-01-24	Compositions and methods
GB0616269D0 (en)	2006-09-27	Methods and compositions